Literature DB >> 16990340

Long term safety of statins should be monitored.

Steven J Haas, Rosana Hage-Ali, Brian G Priestly, Andrew Tonkin, Lisa Demos, John J McNeil, Mark Nelson.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 16990340      PMCID： PMC1570827          DOI： 10.1136/bmj.333.7569.656

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  5 in total

Review 1.  Should we lower cholesterol as much as possible?

Authors:  Uffe Ravnskov; Paul J Rosch; Morley C Sutter; Mark C Houston
Journal:  BMJ       Date:  2006-06-03

2.  Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.

Authors:  C Baigent; A Keech; P M Kearney; L Blackwell; G Buck; C Pollicino; A Kirby; T Sourjina; R Peto; R Collins; R Simes
Journal:  Lancet       Date:  2005-09-27       Impact factor: 79.321

3.  Mortality and incidence of cancer during 10-year follow-up of the Scandinavian Simvastatin Survival Study (4S).

Authors:  Timo E Strandberg; Kalevi Pyörälä; Thomas J Cook; Lars Wilhelmsen; Ole Faergeman; Gudmundur Thorgeirsson; Terje R Pedersen; John Kjekshus
Journal:  Lancet       Date:  2004 Aug 28-Sep 3       Impact factor: 79.321

Review 4.  Carcinogenicity of lipid-lowering drugs.

Authors:  T B Newman; S B Hulley
Journal:  JAMA       Date:  1996-01-03       Impact factor: 56.272

5.  Statin use and cancer risk in the General Practice Research Database.

Authors:  J A Kaye; H Jick
Journal:  Br J Cancer       Date:  2004-02-09       Impact factor: 7.640
  5 in total
  1 in total

1.  Hypolipidemia: a word of caution.

Authors:  Rr Elmehdawi
Journal:  Libyan J Med       Date:  2008-06-01       Impact factor: 1.657
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.